The National Pancreatic Cyst Registry | testing
795
page-template-default,page,page-id-795,ajax_leftright,page_not_loaded,boxed,no_delay

testing

 

Malignant
Potential

Diagnostic
Category

Outcome

Benign

Malignant

Low

Benign

245

386

8

11

SI

141

3

High

SH-Risk

37

40

33

55

Aggressive

3

22

Total

426

66

 

Overall Accuracy

90%

Specificity 0 %

Sensitivity 0 %

NPV

97%

PPV

58%
Performance characteristics for integrated molecular pathology were determined using a standard 2 x 2 table. For purposes of data analysis, molecular diagnoses of “benign” or “statistically indolent” were grouped into a low malignant potential category and molecular diagnoses of “statistically higher risk” or “aggressive” were grouped into a high malignant potential category.